BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2411797)

  • 1. Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2.
    Talmadge JE; Herberman RB; Chirigos MA; Maluish AE; Schneider MA; Adams JS; Philips H; Thurman GB; Varesio L; Long C
    J Immunol; 1985 Oct; 135(4):2483-91. PubMed ID: 2411797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of hyporesponsiveness to augmentation of natural killer cell activity after multiple doses of maleic anhydride divinyl ether: association with decreased numbers of large granular lymphocytes.
    Saito T; Welker RD; Fukui H; Herberman RB; Chirigos MA
    Cell Immunol; 1985 Feb; 90(2):577-89. PubMed ID: 3871375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of hyporesponsiveness of natural killer cells to augmentation of activity after multiple treatments with biological response modifiers.
    Saito T; Ruffman R; Welker RD; Herberman RB; Chirigos MA
    Cancer Immunol Immunother; 1985; 19(2):130-5. PubMed ID: 3845849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow.
    Wiltrout RH; Pilaro AM; Gruys ME; Talmadge JE; Longo DL; Ortaldo JR; Reynolds CW
    J Immunol; 1989 Jul; 143(1):372-8. PubMed ID: 2732472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
    Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
    J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2.
    Zhang SR; Salup RR; Urias PE; Twilley TA; Talmadge JE; Herberman RB; Wiltrout RH
    Cancer Immunol Immunother; 1986; 21(1):19-25. PubMed ID: 3484675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
    Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
    J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2.
    Budzynski W; Chirigos M; Gruys E
    Cancer Immunol Immunother; 1987; 24(3):253-8. PubMed ID: 3594488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of natural killer function in lung, spleen, and peripheral blood lymphocytes: evidence of differential characteristics.
    Lauzon W; Yang H; Lemaire I
    Reg Immunol; 1990-1991; 3(3):145-50. PubMed ID: 2129104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against murine cytomegalovirus infection in aged mice and mice with severe combined immunodeficiency disease with the biological response modifiers polyribosinic-polycytidylic acid stabilized with L-lysine and carboxymethylcellulose, maleic anhydride divinyl ether and colony stimulating factor 1.
    Kunder SC; Wu L; Morahan PS
    Antiviral Res; 1993 Jul; 21(3):233-45. PubMed ID: 7692814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells.
    Brunda MJ; Tarnowski D; Davatelis V
    Int J Cancer; 1986 May; 37(5):787-93. PubMed ID: 2422129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of biological response modifiers on lung natural killer activity.
    Lauzon W; Lemaire I
    Immunopharmacol Immunotoxicol; 1991; 13(3):237-50. PubMed ID: 1719060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in liver-associated natural killer activity by polyribonucleotides.
    Twilley TA; Mason L; Talmadge JE; Wiltrout RH
    Nat Immun Cell Growth Regul; 1987; 6(6):279-90. PubMed ID: 3448488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bimodal effects of MVE-2 on cytotoxic activity of natural killer cell and macrophage tumoricidal activities.
    Piccoli M; Saito T; Chirigos MA
    Int J Immunopharmacol; 1984; 6(6):569-76. PubMed ID: 6511143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of natural killer cell activation: implementation for the control of tumor metastasis.
    Hanna N
    Nat Immun Cell Growth Regul; 1983-1984; 3(1):22-33. PubMed ID: 6235447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of biological response modifiers in a murine model of AIDS. Requirement for augmentation of natural killer cell activity and synergy with oral AZT.
    Black PL; McKinnon KM; Wooden SL; Ussery MA
    Int J Immunopharmacol; 1996 Nov; 18(11):633-50. PubMed ID: 9089007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.
    Hornung RL; Back TC; Zaharko DS; Urba WJ; Longo DL; Wiltrout RH
    J Immunol; 1988 Nov; 141(10):3671-9. PubMed ID: 2460546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in murine gut-associated lymphoid tissues in generating broadly nonspecific cytotoxic cells in response to interferon alpha A/D and interleukin 2.
    Chikkala NF; Gautam SC
    Cell Immunol; 1991 Jul; 135(2):418-30. PubMed ID: 2036676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation of natural killer activity by polyribonucleotides.
    Wiltrout RH; Salup RR; Twilley TA; Talmadge JE
    J Biol Response Mod; 1985 Oct; 4(5):512-7. PubMed ID: 4078596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.